Jemincare
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING3
READOUTS ≤12 MONTHS3
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| JYB1904 NCT06509334 |
P2 | Recruiting | Chronic Spontaneous Urticaria | 135 | 2026-07-15 |
| JMKX003142 will be administered orally NCT06800651 |
P2 | Recruiting | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | 135 | 2027-02-28 |
| JYB1904 NCT07402213 |
P3 | Recruiting | Chronic Spontaneous Urticaria | 240 | 2027-06-07 |
| JYB1904 NCT07459452 |
P2 | Not yet recruiting | Perennial Allergic Rhinitis | 135 | 2027-10 |
| JMKX001899 NCT07242274 |
P3 | Not yet recruiting | NSCLC (Non-small Cell Lung Cancer) | 472 | 2027-12-31 |
| JMKX003142 Tablets NCT07841093 |
P3 | Not yet recruiting | Renal Edema; Nephrogenic Edema | 240 | 2028-04-30 |